Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Non-Small Cell Lung Cancer × quemliclustat × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Oligometastatic Prostate Cancer 1 Cholangiocarcinoma 1 Bile Duct Neoplasms 1 Advanced Non-Small Cell Lung Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Docetaxel 4 Carboplatin 2 zimberelimab 1 surufatinib 1 quemliclustat 1 pemigatinib 1 nimotuzumab 1 lorlatinib 1 Vinorelbine 1 S 1 (combination) 1 Pemetrexed 1 Paclitaxel 1 Gene Expression Profiling 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05676931 2025-10-02

EDGE-Lung

Gilead Sciences

Phase 2 Active not recruiting

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡